Results of the QUALIOR study demonstrated the effectiveness of a SPEP in mitigating the fatigue caused by oral targeted therapies in patients with metastatic cancer.

In this phase 2a study, researchers aimed to determine whether donor fecal microbiota transplantation improved survival in mRCC patients receiving immunotherapy.

Investigators evaluated dual immune checkpoint inhibitors for safety and efficacy in patients with brain metastases from rare cancers.

Investigators examined the relationship between early-onset keratinocyte carcinoma and the risk for other early-onset primary cancers.

Researchers sought to compare the safety and efficacy of pirtobrutinib monotherapy vs bendamustine plus rituximab among treatment-naïve patients with CLL/SLL.

PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.

Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos.

An interim analysis of the prospective BIOPSTAGE trial determined optimal PET thresholds for SUVmax and SUVratio that ...

Researchers sought to determine the effectiveness of patient navigation for younger breast cancer patients, and their attendance to referrals.

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...

The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...

Decrease seen in percent of patients receiving timely treatment among those living in states with least stringent regulations.